Earnings

Earnings Flood Continues: Titan, HUL, ONGC Among 1,600 Firms Reporting This Week

Over 1,600 Indian companies are scheduled to release December-quarter results this week, with Titan expected to post strong revenue growth. The Nifty 50 rose 0.68% on Monday.

James Calloway · · · 4 min read · 292 views
Earnings Flood Continues: Titan, HUL, ONGC Among 1,600 Firms Reporting This Week
Mentioned in this article
GLD $413.38 -3.06% SLV $60.94 -6.55% USO $108.70 -10.48%

India's corporate earnings season enters a pivotal phase this week, with a significant wave of quarterly results scheduled for release. On Monday, February 9, 2026, approximately 170 companies are slated to disclose their financial performance for the October-December 2025 quarter. This initial batch includes prominent names such as BSE Ltd, Zydus Lifesciences, Aurobindo Pharma, and Bata India, setting the tone for a busy period ahead.

A Heavyweight Week of Financial Disclosures

The momentum continues throughout the week, with a total of around 1,600 Indian firms expected to report their December-quarter numbers. The calendar features several market heavyweights, including Titan Company, Mahindra & Mahindra, Hindustan Unilever (HUL), Oil and Natural Gas Corporation (ONGC), Coal India, and Hindustan Aeronautics (HAL). This concentrated release of data from key sectors—from consumer goods and automobiles to energy and industrials—will provide a comprehensive snapshot of the Indian economy's health during the important festive period.

Brokerage Expectations and Market Sentiment

Analysts are closely monitoring these results for critical demand signals and insights into margin pressures. Brokerage firm Motilal Oswal projects Zydus Lifesciences to post a robust 20.9% year-on-year jump in revenue. For Aurobindo Pharma, Kotak Institutional Equities is focusing on U.S. sales, anticipating a 4% sequential growth excluding generic Revlimid. The market responded positively to the earnings momentum on Monday, with the benchmark Nifty 50 index climbing 0.68% and the Sensex gaining 0.58%. This rally was buoyed by optimism surrounding a potential interim trade framework and stronger-than-expected results from State Bank of India.

Dharmesh Kant, head of equity research at Cholamandalam Securities, noted that the trade framework is "a sentimental positive for markets." Adding to the constructive outlook, IIFL Capital observed that earnings downgrades are moderating and upgrades should commence soon. Religare Broking's Ajit Mishra commented on the active earnings calendar as the deluge grinds into its fifth week.

Detailed Forecasts for Key Players

Specific forecasts highlight varied sectoral performances. Titan Company is anticipated to report a standout quarter, with revenue expected to surge nearly 29% year-on-year and profit after tax potentially rising around 35%, according to a consensus of five brokerage estimates cited by the Economic Times. However, Kotak Equities cautions that jewellery margins could narrow by approximately 90 basis points, attributed to a higher mix of gold coin sales and increased marketing expenditure.

In the automotive sector, Kotak is looking for Mahindra & Mahindra to deliver revenue growth of around 30% year-on-year. For state-run energy giant ONGC, Motilal Oswal analysts have flagged potential downside risks, citing project delays in the Krishna-Godavari basin and oil prices dipping below $60 a barrel.

Competitive Dynamics and Sectoral Context

The competitive landscape was underscored by results from Titan's rival, Kalyan Jewellers, which reported a consolidated net profit surge of 90.36% to 4.16 billion rupees and revenue up 42.11% to 103.43 billion rupees. Its shares soared as much as 12.26% on Monday. Executive director Ramesh Kalyanaraman stated, "The current quarter has started off very well despite the volatility in gold prices." This highlights the resilience of consumer demand during the traditional festival and wedding season, a prime period for jewellery and discretionary purchases.

Meanwhile, pharmaceutical companies remain focused on external factors like U.S. pricing dynamics, the pace of new drug launches, and the sustainability of one-off windfalls. The December quarter is a critical period for many businesses, aligning with heightened consumer spending.

Earnings Schedule and Investor Caution

The detailed earnings schedule is packed. Hindustan Unilever is set to release its results on February 12, with an earnings call at 4 p.m. local time. Mahindra & Mahindra's call is scheduled for February 11 from 3:30 p.m. to 4:30 p.m. That same day will also see results from Coal India, ONGC, and Hindustan Aeronautics. On the preceding day, Titan, Eicher Motors, Britannia Industries, Grasim Industries, Apollo Hospitals, and Oil India are all slated to post numbers. Later in the week, companies like Lupin, Biocon, Petronet LNG, and CRISIL are lined up to announce.

While a packed calendar signifies robust corporate activity, it also brings heightened investor scrutiny. Elevated expectations can leave stocks, particularly mid-caps, vulnerable to sharp reactions if margins disappoint or corporate guidance turns cautious. As brokerages have noted, a single sharp move in a key commodity like oil or gold can alter the entire narrative for a company's quarter, reminding investors of the inherent volatility and interconnected risks within the market.

This article is for informational purposes only and does not constitute financial advice or a recommendation to buy or sell any security. Market data may be delayed. Always conduct your own research and consult a licensed financial advisor before making investment decisions.

Related Articles

View All →